Omy Laboratoires secures $11M financing round to help expand into U.S. market
by CM Staff
Omy's SkinAI technology analyzes customers' skin to make personalized dermo-cosmetic products that promote the health of any skin type.
Rachelle Séguin, chemist and president and Andrea Gomez, co-founder and CEO of Omy Laboratoires, announce a $11 million financing round to expand their unique brand that uses SkinAI technology in the U.S, market. (CNW Group/Omy Laboratoires)
MONTREAL — The $11 million investment round led by Crédit Mutuel Equity with participation from Fondaction, BDC Capital’s Thrive Venture Fund and Accelia Capital will allow the Quebec City-based company, which has 27 employees, to hire additional staff and acquire new production equipment to roll out its product line on North American markets.
According to a meta-study published in 2020, nearly 25% of Canadians live with some type of skin condition. Omy’s SkinAI technology analyzes customers’ skin to make personalized dermo-cosmetic products that promote the health of any skin type.
“Our products are formulated to meet clean beauty standards and contain over 95% naturally sourced ingredients, free from harmful substances that can pose a risk to human health and the environment. We meticulously choose ingredients that provide proven benefits, such as hyaluronic acid, peptides, and niacinamide. Our products undergo rigorous testing by dermatologists and are specifically designed for sensitive and atopic skin.” says Rachelle Séguin, chemist and president of the organization.
Established in 2018 with a strong commitment to eco-responsibility, Omy uses 100% vegan ingredients and strives to make its packaging eco-friendly by using bio-based, recyclable plastic or recycled materials by the end of 2023.
“Our company’s mission is to understand each human as a whole to provide responsible, healthy and personalized topical skincare for every stage of life while minimizing the carbon footprint of our operations”, summarizes Andrea Gomez, co-founder and CEO of Omy
“Omy Laboratoires’ already well-established brand and innovative products are positioning the business in strong posture for its next phase of expansion in new markets,” says Michelle Scarborough, Managing Partner, Thrive Venture Fund at BDC Capital. “We’re very proud to participate in the company’s first financing round and support them in their ambitious vision.”
